Literature DB >> 3948471

Factors affecting aminoglycoside disposition: effects of circadian rhythm and dietary protein intake on gentamicin pharmacokinetics.

C J Dickson, M S Schwartzman, J S Bertino.   

Abstract

The effects of dietary protein loading and circadian cycle on the pharmacokinetics of gentamicin were studied in healthy adult men. Ten subjects fasted overnight, and at 8 AM the next morning they received gentamicin, 1.5 mg/kg. Serum and urine samples were obtained over a 6-hour period. In two additional clearance studies with 2-week washout periods in between, 10 subjects were given the same dose of gentamicin at 8 PM in the fasted state and six subjects were also studied in a protein-supplemented (90 gm) state. Pharmacokinetic analysis revealed no significant effect of circadian cycle on gentamicin pharmacokinetic parameters at each of the two fasted periods. In contrast, dietary protein loading resulted in a significant decrease in the elimination t1/2 (P less than 0.05) and an increase in total body clearance compared with the fasted 8 PM study. Urinary excretion of gentamicin was also found to increase significantly (P = 0.03) as a result of protein intake compared with the fasted evening study period. Our study demonstrates the importance of dietary controls in chronopharmacokinetic studies of drugs eliminated predominantly by renal mechanisms.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3948471     DOI: 10.1038/clpt.1986.47

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  13 in total

Review 1.  Chronopharmacology and its application to the development of theophylline treatment schedules for asthma.

Authors:  K R Godfrey
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

Review 2.  The influence of cardiovascular physiology on dose/pharmacokinetic and pharmacokinetic/pharmacodynamic relationships.

Authors:  Pietro Fagiolino; Rosa Eiraldi; Marta Vázquez
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

Review 3.  The influence of nutrition on the systemic availability of drugs. Part II: Drug metabolism and renal excretion.

Authors:  I Walter-Sack
Journal:  Klin Wochenschr       Date:  1987-11-02

4.  Preterm Physiologically Based Pharmacokinetic Model. Part II: Applications of the Model to Predict Drug Pharmacokinetics in the Preterm Population.

Authors:  Khaled Abduljalil; Xian Pan; Amita Pansari; Masoud Jamei; Trevor N Johnson
Journal:  Clin Pharmacokinet       Date:  2020-04       Impact factor: 6.447

5.  Time-restricted feeding schedules modify temporal variation of gentamicin experimental nephrotoxicity.

Authors:  D Beauchamp; C Guimont; L Grenier; M LeBrun; D Tardif; P Gourde; M G Bergeron; L Thibault; G Labrecque
Journal:  Antimicrob Agents Chemother       Date:  1997-07       Impact factor: 5.191

Review 6.  Circadian rhythms: from basic mechanisms to the intensive care unit.

Authors:  Ming-Cheng Chan; Peter M Spieth; Kieran Quinn; Matteo Parotto; Haibo Zhang; Arthur S Slutsky
Journal:  Crit Care Med       Date:  2012-01       Impact factor: 7.598

7.  Altered tobramycin pharmacokinetics during chemoprophylaxis in bladder surgery.

Authors:  F Bressolle; P Joubert; A Gouby; P Costa; M Laracine; T Rebière
Journal:  Antimicrob Agents Chemother       Date:  1991-07       Impact factor: 5.191

8.  Effects of fasting on temporal variations in nephrotoxicity of gentamicin in rats.

Authors:  D Beauchamp; P Collin; L Grenier; M LeBrun; M Couture; L Thibault; G Labrecque; M G Bergeron
Journal:  Antimicrob Agents Chemother       Date:  1996-03       Impact factor: 5.191

9.  Comparison of population pharmacokinetic models for gentamicin in spinal cord-injured and able-bodied patients.

Authors:  T M Gilman; S R Brunnemann; J L Segal
Journal:  Antimicrob Agents Chemother       Date:  1993-01       Impact factor: 5.191

10.  Amikacin pharmacokinetics in patients receiving high-dose cancer chemotherapy.

Authors:  R L Davis; D Lehmann; C A Stidley; J Neidhart
Journal:  Antimicrob Agents Chemother       Date:  1991-05       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.